Page 12 - Dosage Forms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A total of 10,796 oxygen concentrators, 12,269 oxygen cylinders, 19 oxygen generation plants and about 4.2 lakh Remdesivir vials received as global aid were delivered or dispatched through road and air to various states and union territories from April to May 13, the health ministry said on Friday. The major consignments received on May 12/13 from Indonesia, Luxembourg, Oman, South Korea, the UK, USISPF, Finland and Greece include oxygen concentrators (1,506), oxygen cylinders (434) and ventilators/BiPAP/CPAP (58). Cumulatively, 10,796 oxygen concentrators, 12,269 oxygen cylinders, 19 oxyg...

Read more about Set up oxygen storage points within 30 minutes from hospitals: Apollo MD on Business Standard. Apollo Hospitals Group Joint MD Sangita Reddy called for setting up emergency oxygen storage points within 30 minutes distance of all hospitals

The UK will be sending more than 600 pieces of vital medical equipment to India to support it in fight against Covid-19, the UK government announced. The assistance package, funded by the Foreign, Commonwealth & Development Office, includes ventilators and oxygen concentrators from surplus stocks. The Department of Health and Social Care have worked closely with the NHS, as well as suppliers and manufacturers in the UK to identify reserve life-saving equipment that can be sent to India. Recently, India has been reporting high number of Covid-19 cases and deaths while several reports of sho...

Covis Pharma Group COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo-Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide) COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo-Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide) ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses, announced today top-line res...

(0) ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (the "Company"), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses, announced today top-line results from a 400 patient phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ciclesonide metered-dose inhaler in non-hospitalized patients 12 years of age and older with symptomatic COVID-19 infection. The primary endpoint of the study was time to alleviation of COVID-19-rel...